NanoString Technologies

Founded in the United States, NanoString Technologies, Inc. is a biotechnology company dedicated to advancing molecular diagnostics and translational research. The company's core mission is to provide innovative solutions that enable researchers to profile gene transcripts and copy number variations with high precision. NanoString's product lineup includes the CosMx™ Human 6K Discovery Panel and the GeoMx® IO Proteome Atlas, which are designed to uncover complex biological insights and redefine proteomics. Their market focus primarily encompasses life sciences and healthcare sectors, serving a diverse range of research institutions and clinical laboratories.

NanoString Technologies has recently become a part of Bruker Corporation, enhancing its capabilities and market reach. The company has garnered significant attention and investment from leading figures in the biotech industry. Key achievements include the development of robust profiling technologies that have set new standards in gene expression analysis and spatial biology. The overall impact of NanoString Technologies is evident in its contribution to groundbreaking research and the advancement of personalized medicine, helping scientists and clinicians make more informed decisions in their work.